biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, Providers Beyond GLP-1Rs: emerging targets poised
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4





















/assets/images/provider/photos/2759671.jpeg)





